Clinical symptoms, diagnosis, and treatment of neurocysticercosis

被引:367
作者
Garcia, Hector H. [1 ,2 ,3 ]
Nash, Theodore E. [4 ]
Del Brutto, Oscar H. [5 ,6 ]
机构
[1] Inst Ciencias Neurol, Cysticercosis Unit, Lima 1, Peru
[2] Univ Peruana Cayetano Heredia, Ctr Global Hlth Tumbes, Lima, Peru
[3] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru
[4] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[5] Univ Espiritu Santo Ecuador, Sch Med, Guayaquil, Ecuador
[6] Hosp Clin Kennedy, Dept Neurol Sci, Guayaquil, Ecuador
基金
英国惠康基金; 美国国家卫生研究院;
关键词
SOLITARY CYSTICERCUS GRANULOMA; TAENIA-SOLIUM TAENIASIS; CENTRAL-NERVOUS-SYSTEM; CALCIFIED NEUROCYSTICERCOSIS; FOLLOW-UP; CEREBRAL CYSTICERCOSIS; SEIZURE RECURRENCE; HYDROCEPHALUS SECONDARY; COGNITIVE IMPAIRMENT; PRAZIQUANTEL THERAPY;
D O I
10.1016/S1474-4422(14)70094-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The infection of the nervous system by the cystic larvae of Taenia solium (neurocysticercosis) is a frequent cause of seizure disorders. Neurocysticercosis is endemic or presumed to be endemic in many low-income countries. The lifecycle of the worm and the clinical manifestations of neurocysticercosis are well established, and CT and MRI have substantially improved knowledge of the disease course. Improvements in immunodiagnosis have further advanced comprehension of the pathophysiology of this disease. This knowledge has led to individualised treatment approaches that account for the involvement of parenchymal or extraparenchymal spaces, the number and form of parasites, and the extent of degeneration and associated inflammation. Clinical investigations are focused on development of effective treatments and reduction of side-effects induced by treatment, such as seizures, hydrocephalus, infarcts, and neuroinjury.
引用
收藏
页码:1202 / 1215
页数:14
相关论文
共 142 条
[1]   Neurocysticercosis: declining incidence among patients admitted to a large public hospital in Guayaquil, Ecuador [J].
Alarcon, Tomas A. ;
Del Brutto, Oscar H. .
PATHOGENS AND GLOBAL HEALTH, 2012, 106 (05) :310-311
[2]   IMMUNODIAGNOSIS OF TAENIASIS BY COPROANTIGEN DETECTION [J].
ALLAN, JC ;
AVILA, G ;
NOVAL, JG ;
FLISSER, A ;
CRAIG, PS .
PARASITOLOGY, 1990, 101 :473-477
[3]  
[Anonymous], 1 WHO
[4]   FOLLOW-UP OF 146 CHILDREN WITH EPILEPSY AFTER WITHDRAWAL OF ANTIEPILEPTIC THERAPY [J].
ARTS, WFM ;
VISSER, LH ;
LOONEN, MCB ;
TJIAM, AT ;
STROINK, H ;
STUURMAN, PM ;
POORTVLIET, DCJ .
EPILEPSIA, 1988, 29 (03) :244-250
[5]   Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon [J].
Assana, Emmanuel ;
Kyngdon, Craig T. ;
Gauci, Charles G. ;
Geerts, Stanny ;
Dorny, Pierre ;
De Deken, Redgi ;
Anderson, Garry A. ;
Zoli, Andre P. ;
Lightowlers, Marshall W. .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2010, 40 (05) :515-519
[6]   Large cerebral infarction during praziquantel therapy in neurocysticercosis [J].
Bang, OY ;
Heo, JH ;
Choi, SA ;
Kim, DI .
STROKE, 1997, 28 (01) :211-213
[7]   Recommendation for a definition of acute symptomatic seizure [J].
Beghi, Ettore ;
Carpio, Arturo ;
Forsgren, Lars ;
Hesdorffer, Dale C. ;
Malmgren, Kristina ;
Sander, Josemir W. ;
Tomson, Torbjorn ;
Hauser, W. Allen .
EPILEPSIA, 2010, 51 (04) :671-675
[8]   Estimating the Non-Monetary Burden of Neurocysticercosis in Mexico [J].
Bhattarai, Rachana ;
Budke, Christine M. ;
Carabin, Helene ;
Proano, Jefferson V. ;
Flores-Rivera, Jose ;
Corona, Teresa ;
Ivanek, Renata ;
Snowden, Karen F. ;
Flisser, Ana .
PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (02)
[9]   COGNITIVE IMPAIRMENT AND DEMENTIA IN NEUROCYSTICERCOSIS: A CROSS-SECTIONAL CONTROLLED STUDY Reply [J].
Ciampi de Andrade, D. ;
Rodrigues, C. L. ;
Castro, L. H. M. ;
Machado, L. R. ;
Caramelli, P. .
NEUROLOGY, 2010, 75 (11) :1028-1029
[10]   On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship? [J].
Bianchin, Marino Muxfeldt ;
Velasco, Tonicarlo Rodrigues ;
dos Santos, Antonio Carlos ;
Sakamoto, Americo Ceiki .
PATHOGENS AND GLOBAL HEALTH, 2012, 106 (05) :280-285